Tongjitang Chinese Medicines Co.
Baiying Medical Device Park
5th Floor Block B Nanhai Avenue South Nanshan District
Shenzhen,
518067
China - Map
Phone: 86 755 2689 1550
Fax: 86 755 2689 1529
Web Site: http://www.tongjitang.com
| Tongjitang Chinese Medicines Company, through its subsidiaries, engages in the development, manufacture, marketing, and sale of Chinese medicines, nutritional products, and Tibetan recipe-originated plant-based medicines in the Peoples Republic of China. The company also involves in the wholesale and retail of medicines. It offers Xianling Gubao for the treatment of osteoporosis, osteoarthritis, ischemic bone necrosis, and bone fractures; Zaoren Anshen Capsules for the treatment of insomnia; and moisturizing and anti-itching Capsules for the treatment of inflammatory skin conditions. The company also produces and sells Dianbaizhu Syrup for the treatment of vertigo; Compound Glycyrrhiza oral solution for the treatment of upper respiratory infections; Jiao Ti Guo Jiao Bi Capsules that prevent gastritis and ulcers; Bu Shen Yi Lao capsules, which improve memory, breathing, hearing, and general malaise; Xin Nao Kang capsules for the treatment of stroke and coronary artery disease; Jincishen Mixture used as an ancillary to treatment of cancer; Heiguteng capsules for the treatment of rheumatoid arthritis; Chongcao Qingfei capsules for the treatment of Chronic Obstructive Pulmonary Disease; Fengshi Gutong capsules for the treatment of rheumatoid arthritis; and Jingshu Granules for treatment of degenerative osteoarthritis. In addition, its product pipeline candidates comprise Jing Tong Ting, a phase III clinical trial product for menstrual pain; Da An Granules, a phase III ongoing product for anxiety; Yushuda Tablets, a phase III ongoing product for depression; and Dan Xian Kang Gu Capsules, a phase III design ongoing product for ischemic necrosis. Further, the companys pre-clinical products include OA-008 and Xianling Gubao chewable tablets for the treatment of osteoporosis. It sells its products through distributors to hospitals and retail pharmacies. The company was founded in 1995 and is headquartered in Shenzhen, the Peoples Republic of China. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Xiaochun Wang , 41
Chairman and Chief Exec. Officer |
N/A
| N/A | Mr. Charles Wang , 44
Chief Financial Officer |
N/A
| N/A | Mr. Yan Chen Justin , 44
Chief Operating Officer |
N/A
| N/A | Dr. Ling Qin , 49
Chief Technology Officer |
N/A
| N/A | Mr. Eric Chan , 33
Financial Controller |
N/A
| N/A |
|
|
|
Dollar amounts are as of
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.03% Nasdaq 
Profile
